Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients

Objective: To study diabetic and non diabetic patients in UTI, regardingthe prevalence of broad spectrum beta-lactamase producing pathogensand quinolone resistance. Methods: Inclusion criteria for this studywas the presence of positive urine culture and fasting glucose equal toor above 126 mg/dl and...

Full description

Bibliographic Details
Main Authors: Debora da Silva Krenke, Simão Augusto Lottenberg, Marines Dalla Valle Martino, Jacyr Pasternak
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2007-12-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.einstein.br/revista/arquivos/PDF/623-Einstein_P1_Vol5N4_Miolo_Pag.363%20a%20367.pdf
_version_ 1811327660085739520
author Debora da Silva Krenke
Simão Augusto Lottenberg
Marines Dalla Valle Martino
Jacyr Pasternak
author_facet Debora da Silva Krenke
Simão Augusto Lottenberg
Marines Dalla Valle Martino
Jacyr Pasternak
author_sort Debora da Silva Krenke
collection DOAJ
description Objective: To study diabetic and non diabetic patients in UTI, regardingthe prevalence of broad spectrum beta-lactamase producing pathogensand quinolone resistance. Methods: Inclusion criteria for this studywas the presence of positive urine culture and fasting glucose equal toor above 126 mg/dl and below 100 mg/dl. We managed to include 494patients, 210 diabetics and 284 non-diabetics. Results: Escherichiacoli was the most frequently found pathogen in both diabetic andnon-diabetic groups, and significantly more frequent in non diabeticpatients (p = 0.0001) – 60% to 31% when compared to their diabeticcounterparts. Candida albicans infecting the urinary tract was foundin 30% of diabetics and in 16% of non-diabetics (p = 0.003). Broadspectrum beta-lactamase production was more frequently present inKlebsiella pneumoniae, however without significant difference betweenthe groups. Broad spectrum beta-lactamase production was morefrequent in diabetic patients (12%) than in non-diabetics (4%) (p =0.03). Quinolones resistance was more common in diabetics (40%)when compared to non-diabetics (14%) (p = 0.0001). Escherichiacoli is one of the pathogens more frequently found in patients withUTI. Conclusion: Diabetics have a greater likelihood of developingfungal urinary tract infection by Candida albicans, have more broadspectrum beta-lactamase producing Escherichia coli and more quinolone-resistant pathogens.
first_indexed 2024-04-13T15:11:55Z
format Article
id doaj.art-1869c67a90144455aaf40654e54abb21
institution Directory Open Access Journal
issn 1679-4508
language English
last_indexed 2024-04-13T15:11:55Z
publishDate 2007-12-01
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format Article
series Einstein (São Paulo)
spelling doaj.art-1869c67a90144455aaf40654e54abb212022-12-22T02:41:59ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)1679-45082007-12-0154363367Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patientsDebora da Silva KrenkeSimão Augusto LottenbergMarines Dalla Valle MartinoJacyr PasternakObjective: To study diabetic and non diabetic patients in UTI, regardingthe prevalence of broad spectrum beta-lactamase producing pathogensand quinolone resistance. Methods: Inclusion criteria for this studywas the presence of positive urine culture and fasting glucose equal toor above 126 mg/dl and below 100 mg/dl. We managed to include 494patients, 210 diabetics and 284 non-diabetics. Results: Escherichiacoli was the most frequently found pathogen in both diabetic andnon-diabetic groups, and significantly more frequent in non diabeticpatients (p = 0.0001) – 60% to 31% when compared to their diabeticcounterparts. Candida albicans infecting the urinary tract was foundin 30% of diabetics and in 16% of non-diabetics (p = 0.003). Broadspectrum beta-lactamase production was more frequently present inKlebsiella pneumoniae, however without significant difference betweenthe groups. Broad spectrum beta-lactamase production was morefrequent in diabetic patients (12%) than in non-diabetics (4%) (p =0.03). Quinolones resistance was more common in diabetics (40%)when compared to non-diabetics (14%) (p = 0.0001). Escherichiacoli is one of the pathogens more frequently found in patients withUTI. Conclusion: Diabetics have a greater likelihood of developingfungal urinary tract infection by Candida albicans, have more broadspectrum beta-lactamase producing Escherichia coli and more quinolone-resistant pathogens.http://www.einstein.br/revista/arquivos/PDF/623-Einstein_P1_Vol5N4_Miolo_Pag.363%20a%20367.pdfDiabetes mellitusUrinary tractUrinary tract infectionsDrug resistancebacterial
spellingShingle Debora da Silva Krenke
Simão Augusto Lottenberg
Marines Dalla Valle Martino
Jacyr Pasternak
Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients
Einstein (São Paulo)
Diabetes mellitus
Urinary tract
Urinary tract infections
Drug resistance
bacterial
title Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients
title_full Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients
title_fullStr Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients
title_full_unstemmed Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients
title_short Comparison of agents and sensitivity profile in urinary tract infection in diabetic and non-diabetic patients
title_sort comparison of agents and sensitivity profile in urinary tract infection in diabetic and non diabetic patients
topic Diabetes mellitus
Urinary tract
Urinary tract infections
Drug resistance
bacterial
url http://www.einstein.br/revista/arquivos/PDF/623-Einstein_P1_Vol5N4_Miolo_Pag.363%20a%20367.pdf
work_keys_str_mv AT deboradasilvakrenke comparisonofagentsandsensitivityprofileinurinarytractinfectionindiabeticandnondiabeticpatients
AT simaoaugustolottenberg comparisonofagentsandsensitivityprofileinurinarytractinfectionindiabeticandnondiabeticpatients
AT marinesdallavallemartino comparisonofagentsandsensitivityprofileinurinarytractinfectionindiabeticandnondiabeticpatients
AT jacyrpasternak comparisonofagentsandsensitivityprofileinurinarytractinfectionindiabeticandnondiabeticpatients